REPORT ID 6451

Global Hemophilia A Drug Sales Market Report 2017

Publish Date
26-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the global Hemophilia A Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Hemophilia A Drug for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Hemophilia A Drug market competition by top manufacturers/players, with Hemophilia A Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer AG
    BioMarin Pharmaceutical Inc
    Bioverativ Inc
    Catalyst Biosciences Inc
    Chugai Pharmaceutical Co Ltd
    CSL Ltd
    DBV Technologies SA
    Dimension Therapeutics Inc
    EpiVax Inc
    Expression Therapeutics LLC
    Green Cross Corp
    Idogen AB
    Immusoft Corp
    LFB SA
    mAbxience SA
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ATXF-8117
    BAY-1093884
    BIVV-001
    BS-027125
    Concizumab
    CSL-689
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    ASCs

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Hemophilia A Drug Sales Market Report 2017
1 Hemophilia A Drug Market Overview
    1.1 Product Overview and Scope of Hemophilia A Drug
    1.2 Classification of Hemophilia A Drug by Product Category
        1.2.1 Global Hemophilia A Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Hemophilia A Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 ATXF-8117
        1.2.4 BAY-1093884
        1.2.5 BIVV-001
        1.2.6 BS-027125
        1.2.7 Concizumab
        1.2.8 CSL-689
        1.2.9 Others
    1.3 Global Hemophilia A Drug Market by Application/End Users
        1.3.1 Global Hemophilia A Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 ASCs
    1.4 Global Hemophilia A Drug Market by Region
        1.4.1 Global Hemophilia A Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Hemophilia A Drug Status and Prospect (2012-2022)
        1.4.3 China Hemophilia A Drug Status and Prospect (2012-2022)
        1.4.4 Europe Hemophilia A Drug Status and Prospect (2012-2022)
        1.4.5 Japan Hemophilia A Drug Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Hemophilia A Drug Status and Prospect (2012-2022)
        1.4.7 India Hemophilia A Drug Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Hemophilia A Drug (2012-2022)
        1.5.1 Global Hemophilia A Drug Sales and Growth Rate (2012-2022)
        1.5.2 Global Hemophilia A Drug Revenue and Growth Rate (2012-2022)

2 Global Hemophilia A Drug Competition by Players/Suppliers, Type and Application
     2.1 Global Hemophilia A Drug Market Competition by Players/Suppliers
        2.1.1 Global Hemophilia A Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Hemophilia A Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Hemophilia A Drug (Volume and Value) by Type
        2.2.1 Global Hemophilia A Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Global Hemophilia A Drug Revenue and Market Share by Type (2012-2017)
    2.3 Global Hemophilia A Drug (Volume and Value) by Region
        2.3.1 Global Hemophilia A Drug Sales and Market Share by Region (2012-2017)
        2.3.2 Global Hemophilia A Drug Revenue and Market Share by Region (2012-2017)
    2.4 Global Hemophilia A Drug (Volume) by Application

3 United States Hemophilia A Drug (Volume, Value and Sales Price)
    3.1 United States Hemophilia A Drug Sales and Value (2012-2017)
        3.1.1 United States Hemophilia A Drug Sales and Growth Rate (2012-2017)
        3.1.2 United States Hemophilia A Drug Revenue and Growth Rate (2012-2017)
        3.1.3 United States Hemophilia A Drug Sales Price Trend (2012-2017)
    3.2 United States Hemophilia A Drug Sales Volume and Market Share by Players
    3.3 United States Hemophilia A Drug Sales Volume and Market Share by Type
    3.4 United States Hemophilia A Drug Sales Volume and Market Share by Application

4 China Hemophilia A Drug (Volume, Value and Sales Price)
    4.1 China Hemophilia A Drug Sales and Value (2012-2017)
        4.1.1 China Hemophilia A Drug Sales and Growth Rate (2012-2017)
        4.1.2 China Hemophilia A Drug Revenue and Growth Rate (2012-2017)
        4.1.3 China Hemophilia A Drug Sales Price Trend (2012-2017)
    4.2 China Hemophilia A Drug Sales Volume and Market Share by Players
    4.3 China Hemophilia A Drug Sales Volume and Market Share by Type
    4.4 China Hemophilia A Drug Sales Volume and Market Share by Application

5 Europe Hemophilia A Drug (Volume, Value and Sales Price)
    5.1 Europe Hemophilia A Drug Sales and Value (2012-2017)
        5.1.1 Europe Hemophilia A Drug Sales and Growth Rate (2012-2017)
        5.1.2 Europe Hemophilia A Drug Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Hemophilia A Drug Sales Price Trend (2012-2017)
    5.2 Europe Hemophilia A Drug Sales Volume and Market Share by Players
    5.3 Europe Hemophilia A Drug Sales Volume and Market Share by Type
    5.4 Europe Hemophilia A Drug Sales Volume and Market Share by Application

6 Japan Hemophilia A Drug (Volume, Value and Sales Price)
    6.1 Japan Hemophilia A Drug Sales and Value (2012-2017)
        6.1.1 Japan Hemophilia A Drug Sales and Growth Rate (2012-2017)
        6.1.2 Japan Hemophilia A Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Hemophilia A Drug Sales Price Trend (2012-2017)
    6.2 Japan Hemophilia A Drug Sales Volume and Market Share by Players
    6.3 Japan Hemophilia A Drug Sales Volume and Market Share by Type
    6.4 Japan Hemophilia A Drug Sales Volume and Market Share by Application

7 Southeast Asia Hemophilia A Drug (Volume, Value and Sales Price)
    7.1 Southeast Asia Hemophilia A Drug Sales and Value (2012-2017)
        7.1.1 Southeast Asia Hemophilia A Drug Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Hemophilia A Drug Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Hemophilia A Drug Sales Price Trend (2012-2017)
    7.2 Southeast Asia Hemophilia A Drug Sales Volume and Market Share by Players
    7.3 Southeast Asia Hemophilia A Drug Sales Volume and Market Share by Type
    7.4 Southeast Asia Hemophilia A Drug Sales Volume and Market Share by Application

8 India Hemophilia A Drug (Volume, Value and Sales Price)
    8.1 India Hemophilia A Drug Sales and Value (2012-2017)
        8.1.1 India Hemophilia A Drug Sales and Growth Rate (2012-2017)
        8.1.2 India Hemophilia A Drug Revenue and Growth Rate (2012-2017)
        8.1.3 India Hemophilia A Drug Sales Price Trend (2012-2017)
    8.2 India Hemophilia A Drug Sales Volume and Market Share by Players
    8.3 India Hemophilia A Drug Sales Volume and Market Share by Type
    8.4 India Hemophilia A Drug Sales Volume and Market Share by Application

9 Global Hemophilia A Drug Players/Suppliers Profiles and Sales Data
    9.1 Bayer AG
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Hemophilia A Drug Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Bayer AG Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 BioMarin Pharmaceutical Inc
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Hemophilia A Drug Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Bioverativ Inc
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Hemophilia A Drug Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Catalyst Biosciences Inc
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Hemophilia A Drug Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Chugai Pharmaceutical Co Ltd
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Hemophilia A Drug Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 CSL Ltd
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Hemophilia A Drug Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 DBV Technologies SA
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Hemophilia A Drug Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Dimension Therapeutics Inc
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Hemophilia A Drug Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 EpiVax Inc
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Hemophilia A Drug Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Expression Therapeutics LLC
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Hemophilia A Drug Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Green Cross Corp
    9.12 Idogen AB
    9.13 Immusoft Corp
    9.14 LFB SA
    9.15 mAbxience SA

10 Hemophilia A Drug Maufacturing Cost Analysis
    10.1 Hemophilia A Drug Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Hemophilia A Drug
    10.3 Manufacturing Process Analysis of Hemophilia A Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Hemophilia A Drug Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Hemophilia A Drug Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Hemophilia A Drug Market Forecast (2017-2022)
    14.1 Global Hemophilia A Drug Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Hemophilia A Drug Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Hemophilia A Drug Price and Trend Forecast (2017-2022)
    14.2 Global Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Hemophilia A Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Hemophilia A Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Hemophilia A Drug Sales Forecast by Type (2017-2022)
       14.3.2 Global Hemophilia A Drug Revenue Forecast by Type (2017-2022)
       14.3.3 Global Hemophilia A Drug Price Forecast by Type (2017-2022)
    14.4 Global Hemophilia A Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer